Search

Search Constraints

You searched for: Author/Creator Lund, Bendik

Search Results

1. Characteristics of white blood cell count in acute lymphoblastic leukemia: A COST LEGEND phenotype–genotype study. Issue 6 (22nd March 2022)

2. DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial. Issue 4 (April 2017)

3. Genetic predisposition to PEG‐asparaginase hypersensitivity in children treated according to NOPHO ALL2008. (18th November 2018)

4. Host genome variations and risk of infections during induction treatment for childhood acute lymphoblastic leukaemia. (28th January 2014)

5. Impact of body mass index on relapse in children with acute lymphoblastic leukemia treated according to Nordic treatment protocols. (20th September 2020)

6. Individualized 6‐mercaptopurine increments in consolidation treatment of childhood acute lymphoblastic leukemia: A NOPHO randomized controlled trial. (9th November 2017)

7. Low burden of minimal residual disease prior to transplantation in children with very high risk acute lymphoblastic leukaemia: The NOPHO ALL2008 experience. (24th January 2019)

8. NT5C2 germline variants alter thiopurine metabolism and are associated with acquired NT5C2 relapse mutations in childhood acute lymphoblastic leukaemia. Issue 12 (December 2018)

10. TPMT polymorphisms and minimal residual disease after 6-mercaptopurine post-remission consolidation therapy of childhood acute lymphoblastic leukaemia. (20th April 2021)